Sophiris Bio Inc EV/EBIT
¿Qué es el EV/EBIT de Sophiris Bio Inc?
El EV/EBIT de Sophiris Bio Inc es 27.44
¿Cuál es la definición de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de compañías en Sector Health Care en NASDAQ en comparadas con Sophiris Bio Inc
Empresas con ev/ebit similar a Sophiris Bio Inc
- Maxar Technologies tiene EV/EBIT de 27.36
- i3 Verticals Inc tiene EV/EBIT de 27.38
- Dow Inc tiene EV/EBIT de 27.38
- General Electric tiene EV/EBIT de 27.39
- Global X Funds tiene EV/EBIT de 27.40
- UV Germi SA tiene EV/EBIT de 27.41
- Sophiris Bio Inc tiene EV/EBIT de 27.44
- Fine Organic Industries tiene EV/EBIT de 27.45
- Apollo Pipes tiene EV/EBIT de 27.46
- CoreCard tiene EV/EBIT de 27.46
- Firm Capital Apartment Real Estate Investment Trust tiene EV/EBIT de 27.46
- STL Global tiene EV/EBIT de 27.47
- Fidelity D&D tiene EV/EBIT de 27.48